Medical Action Industries, a supplier of medical and disposable surgical products, has appointed John Sheffield as chief financial officer (CFO) and corporate secretary. He will join the executive team responsible for strategy, planning and operations, and will oversee the company’s finance, accounting and investor relation functions.
Sheffield brings 20 years of financial, accounting and strategic transaction experience to Medical Action. He joins from Bank of America Merrill Lynch where he was a senior investment banker providing strategic and financial advice primarily to middle market companies. In addition, Sheffield has worked with other premier investment banks providing advice on mergers and acquisitions (M&As), as well as debt and equity financings. He has represented companies across several industries, with a particular focus on healthcare.
Previously, Sheffield was vice president of corporate development for ReAble Therapeutics (now known as DJO), a portfolio company of the Blackstone Group and global manufacturer of orthopaedic medical devices and services. He began his career as a certified public accountant (CPA) with a predecessor of PricewaterhouseCoopers (PwC).
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more